Back

Structure and functional diversity of antibodies targeting the P. falciparum circumsporozoite protein C-terminal domain

Moskovitz, R.; Burton, I.; Beutler, N.; Gonzalez-Paez, G.; Zalunardo, T.; Bick, M. V.; Ndihokubwayo, J.; Gambuzza, K.; Zhao, J.; Stanfield, R. L.; Zhu, X.; Jain, M.; Winzeler, E. A.; Emerling, D. E.; Ockenhouse, C. F.; MacGill, R. S.; Locke, E.; King, R. C.; Burton, D. R.; Rogers, T. F.; Hangartner, L.; Wilson, I. A.

2026-06-08 microbiology
10.64898/2026.06.06.730512 bioRxiv
Show abstract

The Plasmodium falciparum circumsporozoite protein (PfCSP) is the major surface antigen on Pf sporozoites. WHO-recommended vaccines RTS,S/AS01E and R21/Matrix-M target the PfCSP major repeat region and C-terminal domain (ctCSP). Although multiple studies associated protection with antibody responses to ctCSP, only a few ctCSP-specific monoclonal antibodies (mAbs) have been characterized. Here, crystal structures of 11 Fab-ctCSP complexes reveal how mAbs against the conserved {beta}-epitope region achieve diverse modes of strain-transcending recognition, in contrast to mAbs to the hypervariable -epitope. Consistent with previous studies, ctCSP on sporozoites could be unmasked by mAbs that bind CSP repeats, with unmasking dependent on the mAb fine-specificity and binding mode. In vitro, ctCSP mAbs promoted stronger Fc-receptor signaling, cellular cytotoxicity, and phagocytosis than repeat region mAbs, while mAb combinations targeting distinct PfCSP epitopes modulated Fc-signaling and cellular cytotoxicity. This study provides a rationale for optimization of PfCSP-based immunogens to enhance Fc-mediated contributions to malaria vaccine efficacy.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.